Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind placebo-controlled study of oral doxycycline in Creutzfeldt-Jakob disease
2006-003934-14Phase 2Completed
- Sponsor
- Universitätsmedizin Göttingen
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Creutzfeldt-Jakob disease (CJD) comparing Doxycycline with Placebo (2 arms). Started Mar 2009; status: completed.
02
Drugs
doxycycline
03
Conditions
Creutzfeldt-Jakob disease (CJD)
Beyond the preview
Go deeper on 2006-003934-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003934-14.